van Doorn, Helena C.
Oonk, Maaike H. M.
Fons, Guus
Gaarenstroom, Katja N.
de Hullu, Joanne
van Rosmalen, Joost
van Beekhuizen, Heleen J.
Funding for this research was provided by:
KWF Kankerbestrijding (13292)
Article History
Received: 18 May 2021
Accepted: 7 April 2022
First Online: 23 April 2022
Declarations
:
: The study will be carried out according to the standards outlined in the Declaration of Helsinki. Ethics committee approval has been granted. The Medical Ethical Committee of Erasmus Medical Centre Rotterdam in the Netherlands (trial protocol version 2.0, date March 2nd, 2020) has approved all procedures involving patients. Patients from the following Dutch hospitals may be included: Amsterdam UMC, Erasmus MC (Rotterdam), Leids University MC (Leiden), Radboud UMC (Nijmegen), UMCG (Groningen). Patients will receive verbal and written information from their gynaecologist during the intake for surgery. Informed consent will be obtained from all participants for use of data for analyses. All data will be processed anonymously. Participants will be able to resign at any time without a statement of reasons. The first participant was included May, 28th, 2020.
: Not applicable.
: The authors declare that they have no competing interests.